PHARMAESSENTIA USA CORPORATION

Lobbying client · Massachusetts · filed 2025 to 2026

Biopharmaceutical company that develops treatments for myeloproliferative neoplasms, more

$10,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (61169), not by name.

Firms hired 1

ARNOLD & PORTER KAYE SCHOLER LLP $10,000 6 filings

Reported by year 2 years

2026 $10,000 2 filings
2025 $0 4 filings

Issues lobbied 1

Medicare/Medicaid 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Centers For Medicare and Medicaid Services (CMS) 1
HOUSE OF REPRESENTATIVES 1
SENATE 1

Recent filings 7 total

Q2Y

ARNOLD & PORTER KAYE SCHOLER LLP

2nd Quarter (Apr 1 - June 30) 2026 · posted Jul 17, 2026

View → Q1

ARNOLD & PORTER KAYE SCHOLER LLP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $10,000 income · posted Apr 17, 2026

View → 1AY

ARNOLD & PORTER KAYE SCHOLER LLP

1st Quarter (Jan 1 - Mar 31) 2025 · posted Mar 3, 2026

View → Q4Y

ARNOLD & PORTER KAYE SCHOLER LLP

4th Quarter (Oct 1 - Dec 31) 2025 · posted Jan 14, 2026

View → Q3Y

ARNOLD & PORTER KAYE SCHOLER LLP

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 15, 2025

View → Q2Y

ARNOLD & PORTER KAYE SCHOLER LLP

2nd Quarter (Apr 1 - June 30) 2025 · posted Jul 17, 2025

View → Q1Y

ARNOLD & PORTER KAYE SCHOLER LLP Amended

1st Quarter (Jan 1 - Mar 31) 2025 · posted Apr 17, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.